Jacob Irwin

Jacob Irwin is a Director of Process Development at BridgeBio, specializing in AAV-based Gene Therapy Process Development.2 He has a diverse background with expertise in several areas:

Professional Experience

• Current Role: Director of Process Development at BridgeBio23
• Previous Roles:
  • Co-Founder and CEO of Berkelyn (May 2017 - Present)
  • S.T.E.A.M. Program Manager at NYC Makerspace (April 2019 - May 2024)
  • Co-Founder and CEO of Kimerick Technologies, LLC (March 2012 - May 2017)
  • Lead Engineer at Open Data Registry (April 2012 - November 2012)
  • Managing Director at BPC, Inc. (March 2009 - May 2012)
  • Operations Manager at The Rainier Club (February 2008 - March 2009)1

Education

• Bachelor of Arts from Columbia University in the City of New York (2015 - 2023)
• Associate of Arts and Sciences from Clark College (2007 - 2010 and 2014 - 2015)1

Expertise

Jacob Irwin describes himself as a lifelong learner with specialties in:

• Computer science
• Intellectual property law
• Systems engineering
• International space policy & law
• Econometrics1

Research and Presentations

He has been involved in various research projects and presentations, including:

• Presenter at the 2017 IEEE Undergraduate Research Technology Conference at MIT
• Oral Presenter at the 2020 Inter-Planetary Small Satellite Conference
• Presenter at the Global Space Exploration Conference (GLEX-2021)
• Research Presenter at the 2021 Small Satellite Conference1

Jacob Irwin's LinkedIn username is jacobirwin1, as mentioned in the query.2